OctreoPharm Sciences
OctreoPharm Sciences is focused on the development of new radio pharmaceuticals for neuroendocrine tumors.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed OctreoPharm Sciences Information
OctreoPharm Sciences was acquired by
Ipsen.
The acquisition happend on 2015-06-30.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Berlin
State: Berlin
Zip:
Country: Germany
Financial Info
Stage:
series unknown
Raised Last:
$7M
Raised Total:$7M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
OctreoPharm Sciences GmbH is a Berlin, Germany-based a biopharmaceutical company that focuses on the development of new radio pharmaceuticals for neuroendocrine tumours.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2011 | Venture Round | 2 | $7.2M |
IBB Ventures KfW IBB Ventures KfW |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
